...
首页> 外文期刊>Bioorganic and medicinal chemistry >Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells
【24h】

Polyphenols bearing cinnamaldehyde scaffold showing cell growth inhibitory effects on the cisplatin-resistant A2780/Cis ovarian cancer cells

机译:带有肉桂醛支架的多酚对顺铂耐药A2780 / Cis卵巢癌细胞具有细胞生长抑制作用

获取原文
获取原文并翻译 | 示例

摘要

Ovarian carcinoma remains the most lethal among gynecological cancers. Chemoresistance is a clinical problem that severely limits treatment success. To identify potent anticancer agents against the cisplatin-resistant human ovarian cancer cell line A2780/Cis, 26 polyphenols bearing a cinnamaldehyde scaffold were synthesized. Structural differences in their inhibitory effect on clonogenicity of A2780/Cis cells were elucidated using comparative molecular field analysis and comparative molecular similarity indices analysis. Structural conditions required for increased inhibitory activity can be derived based on the analysis of their contour maps. The two most active compounds (16 and 19) were selected and further characterized their biological activities. We found that compounds 16 and 19 trigger cell cycle arrest at the G2/M phase and apoptotic cell death in cisplatin-resistant A2780/Cis human ovarian cancer cells. The molecular mechanism of compound 16 was elucidated using in vitro aurora A kinase assay, and the binding mode between the compound 16 and aurora A kinase was interpreted using in silico docking experiments. The findings obtained here may help us develop novel plant-derived polyphenols used for potent chemotherapeutic agents. In conclusion, compounds 16 and 19 could be used as promising lead compounds for the development of novel anticancer therapies in the treatment of cisplatin-resistant ovarian cancers.
机译:卵巢癌仍然是最致命的妇科癌症。化学抗性是严重限制治疗成功的临床问题。为了鉴定针对顺铂耐药的人卵巢癌细胞系A2780 / Cis的有效抗癌药,合成了26种带有肉桂醛支架的多酚。使用比较分子场分析和比较分子相似性指数分析阐明了它们对A2780 / Cis细胞克隆形成的抑制作用的结构差异。增强抑制活性所需的结构条件可以基于其轮廓图的分析得出。选择了两种活性最高的化合物(16和19),并进一步表征了它们的生物学活性。我们发现化合物16和19在顺铂耐药A2780 / Cis人卵巢癌细胞中触发G2 / M期的细胞周期停滞和凋亡性细胞死亡。使用体外Aurora A激酶试验阐明了化合物16的分子机理,并使用计算机对接实验解释了化合物16与Aurora A激酶之间的结合方式。此处获得的发现可能有助于我们开发用于有效化学治疗剂的新型植物来源的多酚。总之,化合物16和19可以用作有前途的先导化合物,用于开发新的抗癌疗法,以治疗顺铂耐药的卵巢癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号